ACC: Intensive LDL Cholesterol Targeting Beneficial for Patients With Atherosclerotic CVD

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Amazon Big Spring Sale - Up to 40% off

Medically reviewed by Carmen Pope, BPharm. Last updated on April 2, 2026.

via HealthDay

THURSDAY, April 2, 2026 -- For patients with atherosclerotic cardiovascular disease (ASCVD), targeting a low-density lipoprotein (LDL) cholesterol level of <55 mg/dL results in a lower risk for cardiovascular events, according to a study published online March 28 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans.

Yong-Joon Lee, M.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues randomly assigned 3,048 patients with ASCVD to a target LDL cholesterol level of <55 or <70 mg/dL (intensive and conventional targeting, respectively [1,526 and 1,522 individuals]). Patients were followed for a median of 3.0 years for a primary end point of a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, any revascularization, or hospitalization for unstable angina.

The researchers found that a primary end point occurred in 6.6 and 9.7 percent of patients in the intensive-targeting group and the conventional-targeting group, respectively (hazard ratio, 0.67). The groups had a similar incidence of prespecified safety end points, apart from a lower incidence of creatinine elevation in the intensive-targeting group.

"The consistency across the overall population and key subgroups suggests that the benefit of targeting LDL cholesterol lower than 55 mg/dL is broadly applicable across the spectrum of patients with ASCVD and is not limited to specific patient subsets," lead author Jin Won Kim, M.D., also from the Yonsei University College of Medicine, said in a statement.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-03 01:52

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords